COVID-19 vaccination during pregnancy leads to lower risk of neo-natal death, U of T researchers find

New research shows pregnant mothers who receive mRNA vaccines to prevent COVID-19 have infants and babies who are at lower risk of neonatal death and neonatal intensive care admission.

The research – published in JAMA Pediatrics this week – looked at more than 142,000 live births that happened in Ontario between May 2021 and September 2022.

“I think the findings provide reassuring data on the safety of maternal COVID-19 vaccines during pregnancy, and how they affect newborns and infants,” said Sarah Jorgensen, a PhD candidate in Temerty Faculty of Medicine’s Institute for Medical Science, and first author on the study.

Jorgensen said the study’s results are notable for pregnant women who are contemplating vaccination.

The study also demonstrated that COVID-19 vaccination during pregnancy also led to a lower risk of severe neonatal morbidity, which is when infants who are 28 days old or less have severe medical conditions like seizures, sepsis or a need for respiratory support.

Read the full article at University of Toronto website: Click Here